B4GALNT1 (Q00973) — review notes

Identity and overview

• HGNC symbol B4GALNT1 (synonyms GALGT, SIAT2); UniProt Q00973 (B4GN1_HUMAN); gene on chromosome 12q13.3.
• Product: Beta-1,4 N-acetylgalactosaminyltransferase 1, also called GM2/GD2 synthase and GalNAc-T; EC 2.4.1.92 [file:human/B4GALNT1/B4GALNT1-uniprot.txt "RecName: Full=Beta-1,4 N-acetylgalactosaminyltransferase 1"; "AltName: Full=GM2/GD2 synthase"; "EC=2.4.1.92"].
• Type II single-pass Golgi membrane protein (signal-anchor): TOPO_DOM 1..7 cytoplasmic, TRANSMEM 8..25, TOPO_DOM 26..533 lumenal [file:human/B4GALNT1/B4GALNT1-uniprot.txt "Single-pass type II membrane protein"].
• Belongs to the glycosyltransferase 2 family (CAZy GT12); GT-A fold (Gene3D 3.90.550.10) [file:human/B4GALNT1/B4GALNT1-uniprot.txt "Belongs to the glycosyltransferase 2 family."].
• Homodimer, disulfide-linked (antiparallel catalytic domains) [file:human/B4GALNT1/B4GALNT1-uniprot.txt "SUBUNIT: Homodimer; disulfide-linked."]; established biochemically in PMID:11018043.

Molecular function / catalytic activity

• Committed step of complex ganglioside biosynthesis: transfers GalNAc (beta-1,4) from UDP-GalNAc onto the sialylated (or neutral) lactosylceramide-based precursors. Core reaction:
  ganglioside GM3 + UDP-GalNAc -> ganglioside GM2 + UDP + H(+) (EC 2.4.1.92, RHEA:12588) [file:human/B4GALNT1/B4GALNT1-uniprot.txt "a ganglioside GM3 (d18:1(4E)) + UDP-N-acetyl-alpha-D-"].
• UniProt FUNCTION: "Involved in the biosynthesis of gangliosides GM2, GD2, GT2 and GA2 from GM3, GD3, GT3 and GA3, respectively." [file:human/B4GALNT1/B4GALNT1-uniprot.txt "Involved in the biosynthesis of gangliosides GM2, GD2, GT2"].
• Also acts on GD3 -> GD2 (RHEA:43272 / RHEA:41816) and on LacCer -> GA2 (asialo-GM2) (RHEA:47564 / RHEA:62516) [file:human/B4GALNT1/B4GALNT1-uniprot.txt "a ganglioside GA2 (d18:1(4E))"].
• The enzyme thus feeds the a-series (GM2->GM1...), b-series (GD2->GD1b...) and o-series (GA2->GA1...) complex gangliosides; it is the branch point committing GM3/GD3 to the complex pathways.
• Expression cloning established that the cDNA transfers GalNAc onto GM3 and GD3 by a beta-1,4 linkage to make GM2 and GD2 PMID:1601877; it "suggest that these cDNAs derive from the UDP-GalNAc: GM3/GD3 beta 1,4 N-acetylgalactosaminyltransferase (EC 2.4.1.92) gene." PMID:1601877.
• In-vitro biochemistry: membrane preparations of transfectants showed "de novo synthesis of GM2 or GD2 in in vitro assays using GM3 or GD3, respectively, as ganglioside acceptors." PMID:7487055 — note this quote spans a line wrap; use the substring "novo synthesis of GM2 or GD2 in in vitro assays using GM3 or GD3, respectively".
• Substrate specificity (fusion enzyme + transfectant extracts): produces "not only GM2 and GD2, but also asialo-GM2, GalNAc-sialylparagloboside, and Gal-NAc-GD1a from appropriate acceptors" — the minor acceptors at ~1-3% efficiency of GM2/GD2 PMID:7890749. Kinetics: KM 500 uM for GM3, 40 uM for lactosylceramide [file:human/B4GALNT1/B4GALNT1-uniprot.txt "KM=500 uM for GM3"; "KM=40 uM for lactosylceramide"].
• The specific GO MF is GO:0003947 "(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity" — this is exactly the GM3->GM2 GalNAc-transferase step (verified label in go.db). This is the informative core MF; GO:0008376 (acetylgalactosaminyltransferase activity) and GO:0016758 (hexosyltransferase activity) are its correct-but-general parents.

Biological process / pathway

• Ganglioside biosynthetic process (GO:0001574) is the core BP; supported by IDA/IMP in humans [PMID:7487055; PMID:7890749; PMID:1601877].
• Relative levels of B4GALNT1 vs competing sialyltransferases dictate cell ganglioside composition; over-expression redirected synthesis "away from the b pathway to the a pathway" PMID:7487055.
• UniProt PATHWAY: "Sphingolipid metabolism." [file:human/B4GALNT1/B4GALNT1-uniprot.txt "PATHWAY: Sphingolipid metabolism."]. Reactome places it in "Glycosphingolipid biosynthesis" (R-HSA-9840309) via reaction R-HSA-8856223 "B4GALNT1 dimer transfers GalNAc to gangliosides".

Subcellular location

• Golgi apparatus membrane, single-pass type II [file:human/B4GALNT1/B4GALNT1-uniprot.txt "SUBCELLULAR LOCATION: Golgi apparatus membrane"]. Consistent with Golgi-resident glycosyltransferase acting in the ganglioside assembly line. GO:0000139 (Golgi membrane) is the precise CC term; GO:0005794 (Golgi apparatus) is its parent; GO:0016020 (membrane) is a very general (ProtInc/TAS) call.

Disease

• Autosomal recessive spastic paraplegia 26 (SPG26; MIM:609195) — a complicated hereditary spastic paraplegia with intellectual disability, peripheral neuropathy, dysarthria, cerebellar and extrapyramidal signs, cortical atrophy [file:human/B4GALNT1/B4GALNT1-uniprot.txt "Spastic paraplegia 26, autosomal recessive (SPG26)"]. Causative variants R300C (VAR_070235) and D433A (VAR_070236) identified in PMID:23746551. This ties loss of complex-ganglioside synthesis to neurodegeneration.

Structure

• Three X-ray structures (PDB 9H6J/9H6K/9H6L, residues 47-533) [file:human/B4GALNT1/B4GALNT1-uniprot.txt "PDB; 9H6J"]. Interchain disulfides (C80-C412, C82-C529) plus intrachain C429-C476 from PMID:11018043.

Annotation review reasoning (summary)

• Core MF: GO:0003947 (GM2/GM3-type GalNAc-transferase). ACCEPT the IDA/IMP/TAS annotations to this term; the IEA to same is redundant-but-correct. Keep GO:0008376 (IBA/IEA/ARBA) as correct-but-general parent (KEEP_AS_NON_CORE / general). GO:0016758 hexosyltransferase (InterPro IEA) is an even more general parent — correct but over-general (MARK/general).
• Core BP: GO:0001574 ganglioside biosynthetic process — ACCEPT the human IDA/IMP; IBA/IEA/Ensembl-IEA to same term are correct. GO:0006687 glycosphingolipid metabolic process and GO:0005975 carbohydrate metabolic process (ProtInc TAS) are correct but general; GO:1901135 carbohydrate derivative metabolic process (ARBA IEA) is very general.
• Core CC: GO:0000139 Golgi membrane — ACCEPT (multiple ISS/IEA/TAS). GO:0005794 Golgi apparatus (ISS) is a correct parent; GO:0016020 membrane (ProtInc TAS) is uninformatively general.
• No experimental annotation is contradicted; no REMOVE of experimental annotations. IEA-only very-general terms are kept but flagged as over-general rather than removed, per policy (they are not wrong).